内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by McNamara Robert, 董事. Officer active across 5 companies, notably Xtant Medical Holdings, Inc.. Cumulatively, 22 disclosures have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €263k. History available since 15 August 2021. The latest transaction was disclosed on 28 August 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to McNamara Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
22,214 股Common StockSEC:0001387652-26-000001:0
10,000 股@ US$4.5011.2% 占其流量Common StockSEC:0000950170-25-112234:0
10,000 股@ US$5.0014.1% 占其流量Common StockSEC:0000950170-25-110499:0
10,022 股Common StockSEC:0000950170-25-082439:0
11,000 股@ US$8.3032.2% 占其流量Common StockSEC:0000950170-25-036355:0
10,000 股@ US$10.0936.9% 占其流量Common StockSEC:0000950170-25-024211:0
14,861 股@ US$71.00100.0% 占其流量Common StockSEC:0001562180-24-007707:0
10,000 股@ US$9.0030.9% 占其流量Common StockSEC:0000950170-24-099134:0
162,162 股0Common StockSEC:0001235802-24-000069:0
9,200 股Common StockSEC:0000950170-24-070096:0
18,815 股0Common StockSEC:0001850902-24-000007:1
18,815 股0Common StockSEC:0001850902-24-000007:0
145,180 股0Common StockSEC:0001235802-23-000092:0
3,000 股0Common StockSEC:0001562180-23-005530:0
10,374 股Common StockSEC:0001209191-23-035437:0
2,100 股0Common StockSEC:0001562180-22-006263:0
215,415 股0Common Stock, $0.000001 par valueSEC:0001235802-22-000098:0
9,357 股0Common StockSEC:0001850902-22-000019:0
2,261 股0Common StockSEC:0001562180-21-006823:0
85,337 股0Common Stock, $0.000001 par valueSEC:0001235802-21-000105:0
3,281 股Common StockSEC:0001348324-16-000134:0
2,000 股Common StockSEC:0001348324-16-000127:0
About McNamara Robert
McNamara Robert is Administrateur and has 22 filings in total. Across the 22 sampled filings, buy amounts are EUR 262869 and sell amounts are EUR 1002016, over the period from 2016-01-05 to 2026-06-04; the companies mentioned include AVITA Medical, Inc., Axonics, Inc., Xtant Medical Holdings, Inc., Alpha Teknova, Inc. and LDR HOLDING CORP.